Sanibel Captiva Trust Company’s Charles River Laboratories CRL Stock Holding History

Sanibel Captiva Trust Company’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,389	Closed	-$510K	–	393
2025 Q1	$510K	Sell	3,389 -2,167	-39%	-$363K	0.02%	270
2024 Q4	$1.03M	Sell	5,556 -19,244	-78%	-$3.71M	0.03%	220
2024 Q3	$4.88M	Sell	24,800 -4,611	-16%	-$958K	0.16%	108
2024 Q2	$6.08M	Sell	29,411 -1,079	-4%	-$244K	0.21%	96
2024 Q1	$8.26M	Buy	30,490 +11,974	+65%	+$2.86M	0.28%	86
2023 Q4	$4.38M	Buy	+18,516	New	+$3.64M	0.16%	104

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Sanibel Captiva Trust Company's CRL Position: Q2 2025 in Review

Sanibel Captiva Trust Company sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 3,389 shares — an estimated $510K sold.

Sanibel Captiva Trust Company first reported a position in CRL in Q4 2023 and held it in 6 quarters. The position peaked at $8.26M in Q1 2024. 518 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

Sanibel Captiva Trust Company reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
Sanibel Captiva Trust Company sold 3,389 Charles River Laboratories shares in Q2 2025, an estimated $510K.
Sanibel Captiva Trust Company first reported a position in Charles River Laboratories in Q4 2023 and held it in 6 quarters.
Sanibel Captiva Trust Company's Charles River Laboratories position peaked at $8.26M in Q1 2024.
518 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2025, filed 13 Aug 2025.